Where will Novartis spend the $21B from Roche stake sale? Alnylam buyout could be one: reportnews2021-11-18T12:34:37+00:00November 18th, 2021|Fierce Pharma|
With grants from GSK, Merck and Sanofi, new PSA reminds people all vaccines are still needednews2021-11-18T08:25:20+00:00November 18th, 2021|Fierce Pharma|
With grants from GSK, Merck, Pfizer and Sanofi, new PSA reminds people all vaccines are still needednews2021-11-18T08:25:20+00:00November 18th, 2021|Fierce Pharma|
GSK’s Cabenuva scores thumbs up from England’s NICE, giving HIV patients a new long-acting treatment optionnews2021-11-17T20:34:07+00:00November 17th, 2021|Fierce Pharma|
Epizyme pairs real-life nurse with interactive tool to help follicular lymphoma patients navigate the tough questionsnews2021-11-17T18:56:14+00:00November 17th, 2021|Fierce Pharma|
US readies billions to boost COVID-19 vaccine manufacturing capacity: NYTnews2021-11-17T15:42:52+00:00November 17th, 2021|Fierce Pharma|
Lonza, on $1B expansion push, adds microbial capacity in Switzerlandnews2021-11-17T15:26:42+00:00November 17th, 2021|Fierce Pharma|
Endo scores $90M government contract and will spend another $30M to expand fill-finish operationsnews2021-11-17T14:40:20+00:00November 17th, 2021|Fierce Pharma|
Biogen’s Aduhelm, already battling US skepticism, faces likely European rejectionnews2021-11-17T14:28:58+00:00November 17th, 2021|Fierce Pharma|
Pfizer’s D’Amelio retires, spurring ‘external’ CFO search and prompting company to name new supply chiefnews2021-11-17T14:08:27+00:00November 17th, 2021|Fierce Pharma|
